Pharma Friend? IXICO Seeks To Boost MS Drug Sales With Brain Health Tech
This article was originally published in Clinica
IXICO has struck a partnership with a major pharma player to help improve clinical outcomes of the latter’s blockbuster drug for multiple sclerosis – which will hopefully lead to increased sales – by adding the use of IXICO’s Assessa digital brain health monitoring technology to better manage a serious and potentially fatal side effect of the therapy.
Register for our free email digests: